WEED, Inc. Reports Increased Net Loss and Operational Challenges for Fiscal Year 2025

WEED, Inc. reported a significant increase in its net loss for the fiscal year ending December 31, 2025, amounting to $1.37 million, compared to a loss of $510,716 in the previous year. The company's operating expenses rose sharply to $1.33 million from $530,000 in 2024, primarily driven by increased general and administrative costs, which surged to $1.13 million. The company has not generated any revenue since its inception, and its cash reserves dwindled to $33,130 by the end of 2025, down from $159,355 in 2024. This financial strain has raised substantial doubt about the company's ability to continue as a going concern.

In terms of strategic developments, WEED, Inc. has focused on integrating assets from its acquisition of Hempirical Genetics, LLC, which includes a proprietary seed bank of over 250 cannabis and hemp strains. The company is also pursuing a five-year Cannabis Genomic Study through its subsidiary, Sangre AT, LLC, aimed at creating a global genomic classification of the Cannabis plant. This study is expected to require significant funding, estimated at $15 million, to complete. Additionally, the company entered a strategic partnership with Remergify, Inc. to explore the development of a digital asset ecosystem, including potential launches of WEEDCoin and BUDZCoin.

Operationally, WEED, Inc. has maintained its real estate holdings, notably the "Four Winds of Lake Erie" property in New York, which is seen as a key asset for future business ventures in the hemp and infused beverage markets. The company has also streamlined its international operations by deregistering non-essential subsidiaries in Hong Kong and Australia, aiming to reduce overhead and simplify governance. As of December 31, 2025, the company employed only two full-time staff members, reflecting its lean operational structure.

Looking ahead, WEED, Inc. acknowledges the need for substantial capital to fund its ongoing projects and operational costs. The company plans to pursue additional financing through equity offerings and loans from related parties. However, the current economic conditions and the evolving regulatory landscape surrounding cannabis pose challenges to its growth and operational plans. The management remains optimistic about the long-term potential of the cannabis market, particularly as more states legalize medical and recreational use, but recognizes the risks associated with its business model and the necessity of securing funding to achieve its strategic objectives.